Myeloma Society
@Myeloma_Society
Followers
5K
Following
30
Statuses
1K
To cure myeloma by fostering research, education and excellence in clinical care worldwide.
Joined March 2017
Thank you to all who attended #IMS24 in person and virtually. Save the date for next year's conference, taking place September 17-20 in Toronto, Canada. We look forward to seeing you in 2025!
0
13
37
Check out IMSound, the latest audio series from the International Myeloma Society! Each episode brings insights from top experts on crucial issues in the myeloma community. Listen, download, and share here ➡️
0
0
0
There is still time to register for our Educational Workshop in Johannesburg, South Africa, from February 28 to March 1, 2025! Get ready for engaging lectures and lively roundtable discussions. Don’t miss out—register today! ➡️
0
0
0
West Coast hematologists! Join our FREE NDMM webinar on April 9 to discuss optimizing treatment for Newly Diagnosed patients, including 3- vs 4-drug regimens. Presentations by senior faculty with case discussions.
0
0
1
East Coast hematologists! Join our FREE NDMM webinar on April 2 to discuss optimizing treatment for Newly Diagnosed patients, including 3- vs 4-drug regimens. Presentations by senior faculty with case discussions.
0
0
0
Register today for the 6th Immune Effector Cell Therapies Workshop on March 28-29 in Boston. For details, visit ➡️
0
2
3
The deadline for the IMS Career Development Award is tonight at 11:59 pm EST! Are you ready to apply? For all the details, click here: #MyelomaResearch
0
0
1
The deadline for the IMS Translational Research Award is tonight at 11:59 pm EST! Are you ready to apply? For all the details, click here: #ResearchGrant
0
0
1
Check out IMSound, the latest audio series from the International Myeloma Society! Each episode brings insights from top experts on crucial issues in the myeloma community. Listen, download, and share here ➡️
0
0
0
Please join us for our Educational Workshop in Johannesburg, South Africa, from February 28 to March 1, 2025! Get ready for engaging lectures and lively roundtable discussions. Don’t miss out—register today! ➡️
0
1
3
Register now for the 6th Immune Effector Cell Therapies Workshop on March 28-29 in Boston. For details, visit ➡️
0
0
0
Attention young investigators! 🔬 There is still time to apply for the 5th Annual Career Development Award is here. 📝 The deadline is January 31 so start your application today: #MyelomaResearch
0
0
0
There is still time! Don't forget to apply for the IMS Translational Research Award by Jan 31, 2025! For all the details, click here: #ResearchGrant
0
0
0
West Coast hematologists! Join our FREE NDMM webinar on April 9 to discuss optimizing treatment for Newly Diagnosed patients, including 3- vs 4-drug regimens. Presentations by senior faculty with case discussions.
0
1
6
East Coast hematologists! Join our FREE NDMM webinar on April 2 to discuss optimizing treatment for Newly Diagnosed patients, including 3- vs 4-drug regimens. Presentations by senior faculty with case discussions.
0
0
1
Attention young investigators! 🔬 There is still time to apply for the 5th Annual Career Development Award is here. 📝 The deadline is January 31 so start your application today: #MyelomaResearch
0
1
2
There is still time! Don't forget to apply for the IMS Translational Research Award by Jan 31, 2025! For all the details, click here: #ResearchGrant
0
1
0
Don't miss out! Register today for the 6th Immune Effector Cell Therapies Workshop on March 28-29 in Boston
0
0
1
Please join us for our Educational Workshop in Johannesburg, South Africa, from February 28 to March 1, 2025! Get ready for engaging lectures and lively roundtable discussions. Don’t miss out—register today! ➡️
0
0
0
West Coast hematologists! Join our FREE NDMM webinar on April 9 to discuss optimizing treatment for Newly Diagnosed patients, including 3- vs 4-drug regimens. Presentations by senior faculty with case discussions.
0
0
2
East Coast hematologists! Join our FREE NDMM webinar on April 2 to discuss optimizing treatment for Newly Diagnosed patients, including 3- vs 4-drug regimens. Presentations by senior faculty with case discussions.
0
1
2